Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Group I: Participants Who Did Not Enter RW Period	19
Overall Study	STARTED	Group II: Placebo Subcutaneously (SC) + MTX	11
Overall Study	STARTED	Group III: Placebo + MTX -> Golimumab 30 mg/m^2 + MTX	65
Overall Study	STARTED	Group IV: Golimumab + MTX	78
Overall Study	COMPLETED	Group I: Participants Who Did Not Enter RW Period	0
Overall Study	COMPLETED	Group II: Placebo Subcutaneously (SC) + MTX	0
Overall Study	COMPLETED	Group III: Placebo + MTX -> Golimumab 30 mg/m^2 + MTX	0
Overall Study	COMPLETED	Group IV: Golimumab + MTX	0
Overall Study	NOT COMPLETED	Group I: Participants Who Did Not Enter RW Period	19
Overall Study	NOT COMPLETED	Group II: Placebo Subcutaneously (SC) + MTX	11
Overall Study	NOT COMPLETED	Group III: Placebo + MTX -> Golimumab 30 mg/m^2 + MTX	65
Overall Study	NOT COMPLETED	Group IV: Golimumab + MTX	78

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01230827/flow